{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:20:33Z","timestamp":1790688033185,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,18]]},"DOI":"10.7759\/cureus.64846","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T16:40:46Z","timestamp":1721320846000},"source":"Crossref","is-referenced-by-count":10,"title":["The Evolving Use of Gold Nanoparticles as a Possible Reversal Agent for the Symptoms of Neurodegenerative Diseases: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alan D","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly  R","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Dethloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael  J","family":"Plessala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa  G","family":"Derouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Lopez Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Tirumala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202304082","article-title":"A mechanism underpinning the bioenergetic metabolism\u2010regulating function of gold nanocatalysts","volume":"20","author":"Wang Z","year":"2024","unstructured":"Wang Z, Henriques A, Rouvi\u00e8re L, et al.. A mechanism underpinning the bioenergetic metabolism\u2010regulating function of gold nanocatalysts. Small. 2024, 20:82. 10.1002\/smll.202304082","journal-title":"Small"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58709-w","article-title":"Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis","volume":"10","author":"Robinson AP","year":"2020","unstructured":"Robinson AP, Zhang JZ, Titus HE, et al.. Nanocatalytic activity of clean-surfaced, faceted nanocrystalline gold enhances remyelination in animal models of multiple sclerosis. Sci Rep. 2020, 10:1936. 10.1038\/s41598-020-58709-w","journal-title":"Sci Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02236-z","article-title":"Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials","volume":"21","author":"Ren J","year":"2023","unstructured":"Ren J, Dewey RB 3rd, Rynders A, et al.. Evidence of brain target engagement in Parkinson's disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials. J Nanobiotechnology. 2023, 21:478. 10.1186\/s12951-023-02236-z","journal-title":"J Nanobiotechnology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Neurology Collaborators","year":"2019","unstructured":"GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019, 18:459-80. 10.1016\/S1474-4422(18)30499-X","journal-title":"Lancet Neurol"},{"key":"ref5","article-title":"Parkinsonism","author":"Shrimanker I","year":"2024","unstructured":"Shrimanker I, Tadi P, Schoo C, S\u00e1nchez-Manso JC. Parkinsonism. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson\u2019s disease","volume":"380","author":"Verschuur CV","year":"2019","unstructured":"Verschuur CV, Suwijn SR, Boel JA, et al.. Randomized delayed-start trial of levodopa in Parkinson\u2019s disease. N Engl J Med. 2019, 380:315-24. 10.1056\/NEJMoa1809983","journal-title":"N Engl J Med"},{"key":"ref7","article-title":"Alzheimer Disease","author":"Kumar A","year":"2024","unstructured":"Kumar A, Sidhu J, Goyal A, Tsao JW. Alzheimer Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref8","unstructured":"Amyotrophic Lateral Sclerosis. Practice Essentials, Background, Pathophysiology. (2024). Accessed: June 22, 2024: https:\/\/emedicine.medscape.com\/article\/1170097-overview."},{"key":"ref9","article-title":"Amyotrophic Lateral Sclerosis","author":"Brotman RG","year":"2024","unstructured":"Brotman RG, Moreno-Escobar MC, Joseph J, Munakomi S, Pawar G. Amyotrophic Lateral Sclerosis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref10","unstructured":"Medscape Registration. (2024). Accessed. June 22, 2024: https:\/\/emedicine.medscape.com\/article\/1146199-overview."},{"key":"ref11","article-title":"Multiple sclerosis","author":"Tafti D","year":"2024","unstructured":"Tafti D, Ehsan M, Xixis KL. Multiple sclerosis. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane SC","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, et al.. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020, 19:609-33. 10.1038\/s41573-020-0072-x","journal-title":"Nat Rev Drug Discov"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-017-0047-6","article-title":"Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-\u03b2 protein aggregation","volume":"11","author":"Moore KA","year":"2017","unstructured":"Moore KA, Pate KM, Soto-Ortega DD, et al.. Influence of gold nanoparticle surface chemistry and diameter upon Alzheimer's disease amyloid-\u03b2 protein aggregation. J Biol Eng. 2017, 11:5. 10.1186\/s13036-017-0047-6","journal-title":"J Biol Eng"},{"key":"ref14","unstructured":"Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study). a phase 2, randomised, double-blind, placebo-controlled trial and open label extension - eClinicalMedicine. (2024). Accessed: June 22, 2024: https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589-537000213-4\/fulltext."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.12.013","article-title":"Gold nanoclusters for Parkinson's disease treatment","volume":"194","author":"Gao G","year":"2019","unstructured":"Gao G, Chen R, He M, Li J, Li J, Wang L, Sun T. Gold nanoclusters for Parkinson's disease treatment. Biomaterials. 2019, 194:36-46. 10.1016\/j.biomaterials.2018.12.013","journal-title":"Biomaterials"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.01.020","article-title":"Neuroprotective effect of gold nanoparticles composites in Parkinson's disease model","volume":"14","author":"Hu K","year":"2018","unstructured":"Hu K, Chen X, Chen W, et al.. Neuroprotective effect of gold nanoparticles composites in Parkinson's disease model. Nanomedicine. 2018, 14:1123-36. 10.1016\/j.nano.2018.01.020","journal-title":"Nanomedicine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-019-01780-w","article-title":"Gold nanoparticles treatment reverses brain damage in Alzheimer's disease model","volume":"57","author":"Dos Santos Tramontin N","year":"2020","unstructured":"Dos Santos Tramontin N, da Silva S, Arruda R, et al.. Gold nanoparticles treatment reverses brain damage in Alzheimer's disease model. Mol Neurobiol. 2020, 57:926-36. 10.1007\/s12035-019-01780-w","journal-title":"Mol Neurobiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215366","article-title":"Gold nanoparticle-mediated gene therapy","volume":"14","author":"Kanu GA","year":"2022","unstructured":"Kanu GA, Parambath JB, Abu Odeh RO, Mohamed AA. Gold nanoparticle-mediated gene therapy. Cancers (Basel). 2022, 14:5366. 10.3390\/cancers14215366","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in cancer treatment","volume":"16","author":"Sztandera K","year":"2019","unstructured":"Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B. Gold nanoparticles in cancer treatment. Mol Pharm. 2019, 16:1-23. 10.1021\/acs.molpharmaceut.8b00810","journal-title":"Mol Pharm"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2017.04.027","article-title":"Safety protocol for the gold nanoparticles administration in rats","volume":"77","author":"Muller AP","year":"2017","unstructured":"Muller AP, Ferreira GK, da Silva S, et al.. Safety protocol for the gold nanoparticles administration in rats. Mater Sci Eng C Mater Biol Appl. 2017, 77:1145-50. 10.1016\/j.msec.2017.04.027","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref21","unstructured":"Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via raman imaging in living mice. (2024). Accessed. 2024 Apr 22: https:\/\/pubs.acs.org\/doi\/full\/10.1021\/nn304347g."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda T","year":"2014","unstructured":"Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014, 270:834-41. 10.1148\/radiol.13131669","journal-title":"Radiology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ph13080192","article-title":"Gold nanoparticles: a new golden era in oncology?","volume":"13","author":"Gerosa C","year":"2020","unstructured":"Gerosa C, Crisponi G, Nurchi VM, et al.. Gold nanoparticles: a new golden era in oncology?. Pharmaceuticals (Basel). 2020, 13:192. 10.3390\/ph13080192","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2008.30","article-title":"Nanoparticle-mediated cellular response is size-dependent","volume":"3","author":"Jiang W","year":"2008","unstructured":"Jiang W, Kim BY, Rutka JT, Chan WC. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008, 3:145-50. 10.1038\/nnano.2008.30","journal-title":"Nat Nanotechnol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107528","article-title":"Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: a systematic evidence map protocol","volume":"169","author":"Hester K","year":"2022","unstructured":"Hester K, Kirrane E, Anderson T, Kulikowski N, Simmons JE, Lehmann DM. Environmental exposure to metals and the development of tauopathies, synucleinopathies, and TDP-43 proteinopathies: a systematic evidence map protocol. Environ Int. 2022, 169:107528. 10.1016\/j.envint.2022.107528","journal-title":"Environ Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.15043","article-title":"Societal and family lifetime cost of dementia: implications for policy","volume":"65","author":"Jutkowitz E","year":"2017","unstructured":"Jutkowitz E, Kane RL, Gaugler JE, MacLehose RF, Dowd B, Kuntz KM. Societal and family lifetime cost of dementia: implications for policy. J Am Geriatr Soc. 2017, 65:2169-75. 10.1111\/jgs.15043","journal-title":"J Am Geriatr Soc"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052400","article-title":"Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis","volume":"23","author":"Sever B","year":"2022","unstructured":"Sever B, Ciftci H, DeMirci H, et al.. Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis. Int J Mol Sci. 2022, 23:2400. 10.3390\/ijms23052400","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer's disease and its treatment by different approaches: a review","volume":"216","author":"Srivastava S","year":"2021","unstructured":"Srivastava S, Ahmad R, Khare SK. Alzheimer's disease and its treatment by different approaches: a review. Eur J Med Chem. 2021, 216:113320. 10.1016\/j.ejmech.2021.113320","journal-title":"Eur J Med Chem"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051709","article-title":"Advances in neurodegenerative diseases","volume":"12","author":"Van Schependom J","year":"2023","unstructured":"Van Schependom J, D'haeseleer M. Advances in neurodegenerative diseases. J Clin Med. 2023, 12:1709. 10.3390\/jcm12051709","journal-title":"J Clin Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics","volume":"23","author":"Lamptey RN","year":"2022","unstructured":"Lamptey RN, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022, 23:1851. 10.3390\/ijms23031851","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future. Signal Transduct Target Ther. 2023, 8:248. 10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262875-the-evolving-use-of-gold-nanoparticles-as-a-possible-reversal-agent-for-the-symptoms-of-neurodegenerative-diseases-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T16:40:51Z","timestamp":1721320851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262875-the-evolving-use-of-gold-nanoparticles-as-a-possible-reversal-agent-for-the-symptoms-of-neurodegenerative-diseases-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,18]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.64846","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,18]]}}}